Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Cash from Operations (2020 - 2025)

Maxcyte (MXCT) has disclosed Cash from Operations for 6 consecutive years, with 2689000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 65.62% to 2689000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 34410000.0 through Dec 2025, down 24.63% year-over-year, with the annual reading at 34410000.0 for FY2025, 24.63% down from the prior year.
  • Cash from Operations for Q4 2025 was 2689000.0 at Maxcyte, up from 7458000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 981000.0 in Q4 2023, with the low at 14411000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 5458430.0, with a median of 4738050.0 recorded in 2021.
  • The sharpest move saw Cash from Operations surged 120.94% in 2022, then plummeted 1200.04% in 2023.
  • Over 5 years, Cash from Operations stood at 960250.0 in 2021, then plummeted by 533.83% to 6086400.0 in 2022, then surged by 116.12% to 981000.0 in 2023, then tumbled by 897.25% to 7821000.0 in 2024, then soared by 65.62% to 2689000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 2689000.0, 7458000.0, and 9852000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.